Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1/2 2

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

UNKNOWN 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 3Neoplasms 3Marijuana Abuse 3Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Nausea 1Glioblastoma 1Chronic Pain 1Cachexia 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × nabiximols × Clear all
NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

University of Copenhagen

Phase 2 Withdrawn
Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

NCT03522467 2019-09-25

COPE

Aurora Cannabis Inc

Phase 2 Unknown
40 enrolled

Marijuana Abuse, Neoplasms, Pain, Chronic Pain

NCT00530764 2013-06-20

SPRAY

GWPharm

Phase 2 Completed
360 enrolled 18 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡